Literature DB >> 11137219

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

P Paul1, F A Cabestre, E C Ibrahim, S Lefebvre, I Khalil-Daher, G Vazeux, R M Quiles, F Bermond, J Dausset, E D Carosella.   

Abstract

The nonclassical HLA-G primary transcript is alternatively spliced to generate several mRNAs that have the capacity to encode four membrane bound isoforms, namely HLA-G1, -G2, -G3, and -G4 and two soluble isoforms HLA-G5 and -G6. We aimed at defining the capacity of full length and truncated soluble HLA-G transcripts to be translated in human cell lines. Our study of HLA-G alternative transcripts in various human tissues led us to identify a new splice variant of the HLA-G mRNA, named G7, in which open reading frame continues in intron 2. Due to the presence of a stop codon within intron 2, HLA-G7 transcripts retain the capacity to be translated as soluble truncated HLA-G proteins bearing the alpha1 domain linked to two specific aminoacids encoded by intron 2. Expression vectors containing cDNAs encoding HLA-G5, -G6, and -G7 isoforms were transfected into human cell lines. The presence of translated HLA-G5, -G6, and -G7 proteins was detected in protein extracts of transfected cells by Western blot and immunoprecipitation, but only the full length HLA-G5 soluble isoform could be clearly detected as a secreted protein in both transfected cells supernatants and body fluids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137219     DOI: 10.1016/s0198-8859(00)00197-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  72 in total

1.  Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism.

Authors:  N Lila; N Rouas-Freiss; J Dausset; A Carpentier; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 2.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 3.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 4.  Soluble HLA revisited.

Authors:  William B Tabayoyong; Nicholas Zavazava
Journal:  Leuk Res       Date:  2006-07-24       Impact factor: 3.156

5.  sHLA-G involved in the apoptosis of decidual natural killer cells following Toxoplasma gondii infection.

Authors:  Meiyu Han; Yuzhu Jiang; Kaixue Lao; Xiaoyan Xu; Shaowei Zhan; Yanlin Wang; Xuemei Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.

Authors:  Donna E Hansel; Ayman Rahman; Robb E Wilentz; Ie-ming Shih; Michael T McMaster; Charles J Yeo; Anirban Maitra
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 7.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

8.  Impact of HLA-G in the outcome of vitiligo in Tunisian patients.

Authors:  Akrem Jalel; Aouadi Ridha; Duboisier Laurent; Moureaux Philippe; M H Hamdaoui
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 9.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

10.  Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.

Authors:  Qunying Han; Na Li; Qianqian Zhu; Zhu Li; Guoyu Zhang; Jinghong Chen; Yi Lv; Yawen Wang; Zhengwen Liu; Chunqiu Hao
Journal:  Clin Exp Med       Date:  2012-09-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.